Sárosi, Veronika; Losonczy, György; Francovszky E; Tolnay E; Török, Szilvia; Gálffy, Gabriella; Hegedűs, Balázs; Döme, Balázs; Ostoros, Gyula
(2014)
OBJECTIVES: Erlotinib is an epidermal growth factor receptor tyrosine-kinase inhibitor (EGFR-TKI), used for the treatment of non-small cell lung cancer. As the clinical significance of KRAS mutational status has not yet ...